MarketPeel
Insider Trading Intelligence
Pricing
…
CR

Chris A. Rallis

FENC
DIRECTOR · FENNEC PHARMACEUTICALS INC. · CIK 0001185945
FILING MIX · LIFETIME47%/53%
BUYS
27
SELLS
31
TOTAL VALUE
$1.08M
COMPANIES
2
ACTIVE SINCE
May 2019
HOLDINGS NOW
200,500
AVG SELL PX
$4.34
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Chris A. Rallis, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+50.00%+3.54%+0.23%+3.30%+1.03%—
14d16+25.00%+6.26%+1.12%+2.90%+3.53%—
30d16+56.25%+3.72%+0.94%+2.79%+2.73%—
60d16(1 pending)+53.33%+0.34%+3.16%-2.82%-2.86%—
90d16(1 pending)+46.67%+0.28%+5.04%-4.77%-0.32%—
180d16(1 pending)+46.67%-0.14%+10.14%-10.28%-0.97%—
1y16(3 pending)+61.54%-9.79%+20.82%-30.61%-34.06%—
2y16(7 pending)+55.56%-16.62%+44.60%-61.22%-53.00%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FENC · 200,000 shares · as of Jun 10, 2026
052,297104,593156,890209,186202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 27 buys / 31 sellsCOVERAGE · 29 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000$8.70$174.0K200,000Jun 10, 2026Jun 10, 2026 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
8,346$7.04$58.8K63,077May 11, 2026May 12, 2026 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
14,344$2.44$35.0K71,423May 11, 2026May 12, 2026 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
14,344$2.44$35.0K186,189May 11, 2026May 12, 2026 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
4,062$1.23$5.0K174,344Oct 10, 2025Oct 14, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,775$9.24$16.4K57,079Oct 10, 2025Oct 14, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
4,062$1.23$5.0K58,854Oct 10, 2025Oct 14, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,119$8.71$9.7K54,792Jul 7, 2025Jul 7, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
2,127$2.35$5.0K55,911Jul 7, 2025Jul 7, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
2,127$2.35$5.0K178,406Jul 7, 2025Jul 7, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000$7.88$157.6K200,533Jun 3, 2025Jun 4, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,409$4.95$7.0K53,784Apr 11, 2025Apr 11, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
2,173$2.30$5.0K180,533Apr 11, 2025Apr 11, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
2,173$2.30$5.0K55,193Apr 11, 2025Apr 11, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,186$6.82$8.1K53,020Feb 14, 2025Feb 14, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
1,992$2.51$5.0K182,706Feb 14, 2025Feb 14, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
1,992$2.51$5.0K54,206Feb 14, 2025Feb 14, 2025 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
10,000$2.69$26.9K58,623Dec 2, 2024Dec 2, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
6,409$6.14$39.4K52,214Dec 2, 2024Dec 2, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
10,000$2.69$26.9K184,698Dec 2, 2024Dec 2, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000$5.58$111.6K196,658Aug 15, 2024Aug 19, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
1,792$2.79$5.0K47,630Jul 5, 2024Jul 7, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,173$6.03$7.1K46,457Jul 5, 2024Jul 7, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
1,792$2.79$5.0K179,802Jul 5, 2024Jul 7, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
800$10.45$8.4K44,449Apr 15, 2024Apr 15, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
1,389$10.45$14.5K45,838Apr 15, 2024Apr 15, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
1,389$3.60$5.0K181,594Apr 15, 2024Apr 15, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
2,114$10.97$23.2K40,920Mar 26, 2024Mar 27, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
4,329$2.31$10.0K182,983Mar 26, 2024Mar 27, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
4,329$2.31$10.0K45,249Mar 26, 2024Mar 27, 2024 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,390$10.90$15.2K44,788Dec 26, 2023Dec 28, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
3,144$1.59$5.0K46,178Dec 26, 2023Dec 28, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
3,144$1.59$5.0K184,168Dec 26, 2023Dec 28, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
269$8.25$2.2K43,034Nov 20, 2023Nov 21, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
673$7.85$5.3K43,303Aug 18, 2023Aug 18, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
16,666$0.72$12.0K50,772Jul 24, 2023Jul 24, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
16,666$0.72$12.0K187,312Jul 24, 2023Jul 24, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
6,796$8.17$55.5K43,976Jul 24, 2023Jul 24, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000——209,186Jun 12, 2023Jun 13, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
833$7.36$6.1K31,958May 19, 2023May 19, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
925$7.36$6.8K31,033May 19, 2023May 19, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
986$8.34$8.2K32,791Apr 17, 2023Apr 17, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
1,700$2.94$5.0K33,777Apr 17, 2023Apr 17, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
4,166$2.40$10.0K34,184Mar 3, 2023Mar 3, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
2,177$9.09$19.8K32,077Mar 3, 2023Mar 3, 2023 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
333$7.99$2.7K30,018Nov 17, 2022Nov 17, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
4,762$1.05$5.0K32,419Oct 20, 2022Oct 20, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
2,068$8.26$17.1K30,351Oct 20, 2022Oct 20, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
11,111$0.45$5.0K32,036Jul 18, 2022Jul 18, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
SALE
4,379$6.70$29.3K27,657Jul 18, 2022Jul 18, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000——20,000Jun 14, 2022Jun 16, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
9,259$0.54$5.0K20,925Mar 8, 2022Mar 8, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
8,333$0.60$5.0K11,666Mar 8, 2022Mar 8, 2022 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASE
3,333$1.50$5.0K3,333Oct 21, 2021Oct 21, 2021 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000——20,000Jun 29, 2021Jun 30, 2021 ↗View →
FENC
FENNEC PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,000——20,000Aug 13, 2020Aug 14, 2020 ↗View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
500——500May 1, 2020Jun 15, 2020 ↗View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
500——500May 1, 2019Jun 15, 2020 ↗View →
Other insiders · FENC
Loading peer insiders…
About this filer
CIK 0001185945
ROLE
Director
PRIMARY
FENC
COMPANIES
2
ACTIVE SINCE
May 2019
MARKETPEEL · /INSIDER/0001185945DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback